Your browser doesn't support javascript.
loading
Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis / 中华医学杂志(英文版)
Chinese Medical Journal ; (24): 2194-2201, 2015.
Article Dans Anglais | WPRIM | ID: wpr-335634
ABSTRACT
<p><b>BACKGROUND</b>Systemic chemotherapy (SC) is the recommended treatment for gastric cancer with liver metastasis. However, the improvement in survival has been disappointing. The aim of this study was to compare the therapeutic efficacy of gastrectomy with transarterial chemoembolization plus SC (GTC) and SC alone for gastric cancer with synchronous liver metastasis.</p><p><b>METHODS</b>From January 2008 to December 2013, 107 gastric cancer patients with synchronous liver metastasis attending the four participating centers were enrolled in this multicenter, ambispective, controlled cohort study. Patients who underwent GTC (n = 32) were compared with controls who were received SC alone (n = 75). The primary endpoints of the study were overall survival (OS) and progression-free survival (PFS). The secondary endpoints were response rate to treatment and treatment-related adverse effects.</p><p><b>RESULTS</b>The median OS was 14.0 months (95% confidence interval [CI ] 13.1-14.9 months) in the GTC treatment group and 8.0 months (95% CI 6.6-9.4 months) in SC group, this difference being statistically significant (P < 0.001). The median PFS was significantly longer in the GTC than in the SC group (5 months, 95% CI 2.2-7.8 months vs. 3 months, 95% CI 2.3-3.4 months, respectively) (P < 0.001). The rate of response to treatment was significantly better in the GTC than the SC group (59.4% vs. 37.4%, respectively) (P = 0.035). According to multivariate analysis, OS in patients receiving combination treatment was significantly correlated with the size (P = 0.037) and extent of liver metastases (P < 0.001). PFS was also correlated with the extent of liver metastases (P = 0.003).</p><p><b>CONCLUSIONS</b>GTC is more effective than SC alone in patients with gastric cancer with synchronous liver metastasis. GTC therapy prolongs the survival of selected gastric cancer patients with synchronous liver metastasis.</p>
Sujets)
Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Anatomopathologie / Tumeurs de l&apos;estomac / Thérapeutique / Protocoles de polychimiothérapie antinéoplasique / Études de cohortes / Chimioembolisation thérapeutique / Association thérapeutique / Désoxycytidine / Fluorouracil / Gastrectomie Type d'étude: Essai clinique contrôlé / Etude d'étiologie / Etude d'incidence / Étude observationnelle / Facteurs de risque Limites du sujet: Adulte / Adulte très âgé / Femelle / Humains / Mâle langue: Anglais Texte intégral: Chinese Medical Journal Année: 2015 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Anatomopathologie / Tumeurs de l&apos;estomac / Thérapeutique / Protocoles de polychimiothérapie antinéoplasique / Études de cohortes / Chimioembolisation thérapeutique / Association thérapeutique / Désoxycytidine / Fluorouracil / Gastrectomie Type d'étude: Essai clinique contrôlé / Etude d'étiologie / Etude d'incidence / Étude observationnelle / Facteurs de risque Limites du sujet: Adulte / Adulte très âgé / Femelle / Humains / Mâle langue: Anglais Texte intégral: Chinese Medical Journal Année: 2015 Type: Article